Cagrilintide: mechanism of action and potential benefits
Cagrilintide is a long-acting analogue of amylin, a pancreatic peptide normally released alongside insulin after meals. Amylin helps communicate satiation and coordinates the rate at which nutrients move from the stomach.
99%+ HPLC purity
Batch COA records
QR vial verification
Scientific product profiles
Mechanism of action
Cagrilintide activates amylin and calcitonin receptor complexes in the brain. This strengthens satiation signals, can reduce meal size and food intake, and slows gastric emptying. Its actions complement rather than duplicate the GLP-1 pathway.
Potential benefits
May increase fullness after meals
May reduce calorie intake and food cravings
Associated with body-weight reduction
May complement GLP-1-based metabolic effects
Evidence context: Early human data support meaningful effects on appetite and weight, while longer-term outcomes continue to be defined.
Product data and verification
DEU Peptides connects the Cagrilintide catalog entry with identity, purity, storage, and batch data. A registered QR code can confirm the product name, concentration, batch ID, vial ID, and date fields.
Cagrilintide activates amylin and calcitonin receptor complexes in the brain. This strengthens satiation signals, can reduce meal size and food intake, and slows gastric emptying. Its actions complement rather than duplicate the GLP-1 pathway.
What potential benefits are associated with Cagrilintide?
May increase fullness after meals; May reduce calorie intake and food cravings; Associated with body-weight reduction; May complement GLP-1-based metabolic effects.
How strong is the evidence for Cagrilintide?
Early human data support meaningful effects on appetite and weight, while longer-term outcomes continue to be defined.
This scientific overview is general information and does not replace individualized medical advice, diagnosis, or treatment.